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G protein-coupled receptor kinase interactor 2 (GIT2) is a signaling scaffold protein involved in
regulation of cytoskeletal dynamics and the internalization of G protein-coupled receptors
(GPCRs). The short-splice form of GIT2 is expressed in peripheral T cells and thymocytes. However,
the functions of GIT2 in T cells have not yet been determined. We show that treatment with Con
A in a model of polyclonal T-lymphocyte activation resulted in marked inhibitions in the
intrahepatic infiltration of inflammatory cells, cytokine response and acute liver failure in
Git2/mice. CD4+ T cells from Git2/mice showed significant impairment in proliferation, cytokine
production and signal transduction upon TCR-stimulated activation. Our results suggested that GIT2
plays an important role in T-cell function in vivo and in vitro.
 2015 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Immune cells, including lymphocytes and Kupffer cells, consti-
tute approximately 45% of the total non-hepatocyte cells in the
normal liver [1,2]. Nearly all of the innate immune cells in the liver
have been reported to be involved in the diverse liver injuries
observed in experimental animal models and/or human clinical
investigations [1]. It is well established that Con A induced liver
damage in mice is a typical model that closely resembles several
pathological properties of human viral or autoimmune hepatitis
[3]. Activated T cells play a critical role in Con A-induced liver dam-
age [4]. Tiegs found that pretreatment of mice with monoclonal
anti-CD4 antibody inhibited Con A-induced hepatitis, suggesting
that CD4+ T lymphocytes are required for the initiation of the
immunological response [4]. In addition, immune cells, including
CD8+ T cells, natural killer (NK) cells, natural killer T cells,
Kupffer cells/macrophages, neutrophils and eosinophils, have alsobeen reported to be involved in Con A-induced hepatitis by either
cell-to-cell contact or the secretion of pro-inflammatory cytokines
or reactive oxygen species [3].
G protein-coupled receptor kinase interacting protein 2 (GIT2)
is a signaling scaffold protein involved in the regulation of
cytoskeletal dynamics, GPCR internalization and membrane traf-
ficking [5]. GIT2 has numerous splice variants, and the longest
splice form of GIT2 (GIT2-long) is expressed in a wider range of
cells, whereas GIT2-short is specific to immune cells [6]. GIT2 is
a ubiquitous multi-domain protein that has an N-terminal ARF-
GAP domain, three Ank repeats, a Spa2-homology domain (SHD),
a coiled-coil (CC) domain and a paxillin-binding site (PBS) [5].
The GIT2-short lacks the CC domain and PBS [5]. GIT2 regulates
diverse cellular functions through interacting with various pro-
teins. For example, GIT2 agonist GPCR endocytosis through regu-
lating ARFs via ARF-GPA domain and the phosphorylation of GIT2
at PBS via Src and FAK is required for its recruitment to focal com-
plexes, which is essential for the formation of normal lamellipodia
during cell spreading [6,7]. In addition, the main binding partner
for the SHD of GIT2 is PIX, through which GIT2 can regulate
cytoskeletal dynamics via interacting with PAK1 and the small
GTPases Rac1 and Cdc42 [8]. GIT/PIX complexes are known to func-
tion as scaffolds for a variety of signaling proteins, including GRKs,
PAKs, FAK, the MEK1-ERK1/2 mitogen-activated protein kinases,
and phospholipase C [5]. Previous studies have shown that GIT
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PAK in T cells and that this complex is recruited to the T cell
immunological synapse by PIX [9,10]. The mutation of PIX in mice
results in neutrophil that are defective in orienting and migrating
toward a chemoattractant, and this phenotype resembles that of
GIT2-knockout mice [11–13]. Moreover, PIX-knockout T lympho-
cytes showed defective TCR-induced proliferation and signaling
but enhanced basal migration [12]. Interestingly, Git2/ double-
positive (DP) thymocytes display increased migration toward
SDF-1 and CCL25 in vitro, suggesting that GIT2 plays a key role in
regulating the chemokine-mediated motility of DP thymocytes
[14]. In addition, through analyzing a genome-wide association
study (GWAS) dataset, significant association between the single
nucleotide polymorphisms (SNP) in GIT2 and abnormal values of
HDL cholesterol has been reported [15]. Clinically, in addition to
metabolic syndrome, it is generally thought that an abnormal
value of HDL-C results from liver dysfunction [16], which suggests
a potential role of GIT2 in liver disease. Taken together, these data
show that GIT2 may play an important role in the regulation of T
cell function and in liver disease.
In this study, we utilized Git2/ mice to investigate the role of
GIT2 in immune cells during T cell-mediated hepatitis. We found
that GIT2 deficiency in mice led to a spontaneous reduction of
basal CD4+ T cells and NKT cells in the liver. Treatment with Con
A in a model of polyclonal T lymphocyte activation resulted in
marked inhibitions in the intrahepatic infiltration of inflammatory
cells, cytokine response and acute liver failure in Git2/ mice.
CD4+ T cells from Git2/ mice showed significant impairments
in proliferation, cytokine production and signal transduction upon
TCR-stimulated activation. Our data demonstrate that GIT2 plays
an important role in Con A-induced hepatitis and may therefore
be a potential target for therapeutic intervention in acute liver
diseases.
2. Results
2.1. GIT2 depletion attenuated Con A-induced immunological hepatic
injuries
Heterozygous GIT2-knockout mice were bred to produce Git2+/+
controls and homozygous GIT2-knockout (Git2/) mice. Positive
founder mice were identified by RT-PCR and Western bolt analyses
(Fig. 1A and B). GIT2 was completely absent from the total thymo-
cytes, splenic CD4+ T cells and liver tissues, as determined using an
antibody against the mouse GIT2. In agreement with previous
reports [13], adult Git2/ mice showed no gross phenotypic
abnormalities but often developed splenomegaly (Fig. 1C and D)
and an increased CD4+/CD8+ ratio in the liver MNCs (Table 1). To
examine the effects of GIT2 on immune-mediated hepatitis, we
applied the Con A-induced hepatitis model in six- to eight-week-
old male Git2+/+ and Git2/ mice. We observed that the serum
AST and ALT levels after the injection of 15 mg/kg Con A were sig-
nificantly lower in Git2/ mice compared with Git2+/+ mice
(Fig. 1E). Histological analyses of liver tissue sections obtained
24 h after the administration of 15 mg/kg Con A indicated that
Git2/ mice were less sensitive to Con A-induced hepatic injury
(Fig. 1F). Liver tissue sections of Git2/ mice showed several soli-
tary areas of necrotic tissue characterized by standard morphologic
criteria (Fig. 1F – d–f), and the majority of hepatocytes were not
affected. However, liver tissue sections of Git2+/+ mice showed
widespread areas of necrosis (Fig. 1F – a) with extensive infiltra-
tion of mononuclear cells within the liver lobules (Fig. 1F – b)
and around the central veins and portal tracts (Fig. 1F – c), indicat-
ing an ongoing inflammatory process. Consistent with these
findings, the percentage of liver tissue with necrotic damage wasmarkedly lower in Git2/ mice (Fig. 1G). The livers of Git2/ mice
also demonstrated a significant decrease in hepatocyte apoptosis
24 h after treatment with 15 mg/kg Con A (Fig. 1H): the liver of
Git2+/+ mice showed 37% hepatocyte apoptosis, whereas only 13%
apoptosis was observed in the Git2/ mice. Taken together, these
data indicated that mice deficient in GIT2 appeared highly resistant
to liver injuries induced by Con A.
To test whether GIT2 depletion also protects mice against
chemically induced liver injury, Git2+/+ and Git2/ mice were
injected i.p. with CCl4. The results showed no significant
differences in liver injury between Git2+/+ and Git2/ mice
(Fig. 2A and B), which may be due to a different mechanism of liver
injury in this model, indicating the potential role of GIT2 in T
cell-mediated liver injury.
2.2. GIT2 depletion suppressed lymphoid cells infiltration to liver after
Con A treatment
To examine whether GIT2 depletion affects the influx of MNCs
in the liver after Con A injection, we first analyzed the steady-
state composition of immune cells in the liver of Git2/ mice.
The liver MNCs were isolated and subjected to flow cytometry
analysis. As shown in Fig. 3A, the total number of mononuclear
cells in the liver of Git2/ mice was equal to that in Git2+/+ mice.
However, the numbers of basal CD4+ T cells and NKT cells were sig-
nificantly reduced in the liver of Git2/ mice, whereas the CD8+
cells were increased compared with the Git2+/+ controls. Other liver
MNC subsets, such as NK cells and B cells, were not influenced
(Fig. 3A).
After Con A injection, although increased, the number of MNCs
in the liver of Git2/ mice was significantly lower than that found
in Git2+/+ mice (Fig. 3A). Moreover, the degree of increase was
much smaller in the number of Git2/ liver MNC subsets, includ-
ing CD4+, CD8+ T cells and CD19+ B cells (Fig. 3A). For example, the
absolute number of CD4+ T cells in the liver of Git2+/+ mice
increased approximately two-fold but only increased 20% in
GIT2/ mice. Consistent with the previous report [17], NKT cells
were markedly decreased in both Git2/ and Git2+/+ mice.
Additionally, there was no significant difference in the number of
NK cells between Git2+/+ and Git2/ mice. We also analyzed the
percentage of these cell types and the pattern is similar with their
number (Table 2). Although the absolute number was the same
with control, the percentage of T regulatory cells (Tregs;
CD4+CD25+Foxp3+) in the liver of Git2/ mice was significantly
higher than that in Git2+/+ mice after Con A injection (Fig. 3B). In
addition, we assessed the absolute number and the percentage of
Tregs in splenocyte. As shown in Fig. 3C, the number of splenic
mononuclear cells in Git2/ mice was more than 2-fold higher
than that of Git2+/+ mice, which consistent with previous reporter
[13]. Prior to Con A treatment, no statistically significant difference
was detected in the populations of CD4+ and Tregs in spleens of
Git2/ and Git2+/+ mice. After Con A treatment, the absolute num-
ber and percentage of Tregs were significantly higher in Git2/
spleen than Git2+/+. We also detected the apoptosis of liver MNCs
and splenocyte and absence of GIT2 did not significantly change
the Con A-induced apoptosis (Fig. 3D). These data suggest that
GIT2 deficiency attenuate Con A-induced infiltration of inflamma-
tory cells in the liver which protect Git2/ mice from liver injury.
2.3. Lower levels of proinflammatory cytokines in Git2/ mice after
Con A injection
Proinflammatory cytokine production is a key component of
Con A-induced liver injury. We therefore assessed the levels of
TNF-a, INF-c, IL-2, IL-4, IL-6, IL-17A, and IL-10 in the mice serum.
Fig. 1. GIT2 depletion attenuated Con A-induced immunological hepatic injuries. (A) Genomic PCR using genomic DNA from the mouse tail of Git2+/+, Git2+/, and Git2/
mice. (B) GIT2 expression in thymocytes, splenic CD4+ T cells and liver tissues were analyzed using mouse GIT2 antibody. (C) Representative photographs of spleens in Git2+/+
and Git2/mice. (D) Total splenic cell numbers from Git2+/+ and Git2/mice (n = 6). Graphs in figures showmean ± s.e.m., *P < 0.05. (E) Serum ALT and AST levels from Git2+/+
and Git2/mice (n = 3) were determined at the indicated time points following 15 mg/kg Con A injection. (F and G) 24 h after 15 mg/kg Con A injection, mice were sacrificed
and the liver tissues were stained with H&E for histopathological and morphological analysis. Scare bar, 50 lm (F). The percentage of necrotic area was quantitated using
ImageJ software, and values are the mean ± SD of five fields of measurements (G). (H) TUNEL staining was performed on liver sections from Git2+/+ and Git2/ mice with
15 mg/kg Con A treatment. The TUNEL-positive cells are shown by arrows, and values are the mean ± SD of five fields of measurements. Scare bar, 50 lm. The results were
representative of three independent experiments and error bars represent standard deviations (*P < 0.05, **P < 0.01, ***P < 0.001).
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Table 1
Lymphocyte populations in Git2+/+ and Git2/ mice [mean ± SD, n = 3–6].
Tissue and cells population Cells [%] t P
Git2+/+ Git2/
Thymus
CD4CD8 6.2 ± 2.8 7.4 ± 2.1 0.587 0.589
CD4+CD8+ 76.9 ± 6.1 78.8 ± 1.4 0.526 0.647
CD4+CD8 10.2 ± 2.0 9.7 ± 2.0 0.274 0.797
CD4CD8+ 6.7 ± 2.3 4.0 ± 0.9 1.839 0.140
Spleen
CD4+ 57.3 ± 4.6 53.0 ± 2.5 1.415 0.230
CD8+ 36.6 ± 3.9 41.1 ± 2.7 1.640 0.176
Lymph nodes
CD4+ 62.9 ± 3.9 62.3 ± 8.4 0.160 0.876
CD8+ 34.1 ± 3.3 34.4 ± 7.3 0.087 0.932
Liver
CD4+ 61.9 ± 2.9 42.8 ± 4.2*** 9.210 0.000
CD8+ 22.1 ± 3.1 37.1 ± 5.7** 5.707 0.001
T Cells from the thymus, spleen, lymph nodes and liver of 8-week-old Git2+/+ and
GIT2/ littermates were stained with anti-CD4-APC and anti-CD8-PerCP-Cy5.5 and
analyzed by FACS. Data are means ± standard deviations. Significance was verified
by Student’s t test.
** P < 0.01.
*** P < 0.001 versus Git2+/+ mice.
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were found between vehicle-treated Git2+/+ and vehicle-treated
Git2/ mice. Three hours after Con A administration, the serum
levels of TNF-a, IFN-c, IL-2, IL-4, IL-6, and IL-17A were increased
significantly in Git2+/+ mice, and the levels of INF-c and IL-6 contin-
ued to increase 6 h post Con A treatment. However, compared with
Con A-treated Git2+/+ mice at 3 h after Con A administration, the
analysis of the levels of proinflammatory cytokines showed
significant reductions in the TNF-a (55% reduction), IFN-c (30%Fig. 2. The effect of GIT2 depletion on CCl4 induced liver injury. (A) Serum ALT and AST lev
of CCl4 at the dosage of 1 ml/kg (1:3 diluted in corn oil) intraperitoneally (i.p.). (B) 12 h af
tissues were fixed, sectioned and stained with H&E for histopathological and morpholo
using ImageJ software and values are the mean ± SD of five fields of measurements.reduction), IL-2 (50% reduction), IL-4 (90 % reduction), IL-6 (40%
reduction) and IL-17A levels (75% reduction) in Git2/ mice
(Fig. 4A). Interestingly, the level of IL-10, an anti-inflammatory
cytokine, was significantly increased both 3 and 6 h post Con A
injection in Git2/ mice.
We also observed that the mRNA cytokine levels in the hepatic
homogenate in the Con A model groups increased significantly in
comparison to those in the saline control groups (Fig. 4B); how-
ever, after Con A injection, the TNF-a, IFN-c, IL-2, IL-4, and IL-6
expression levels were increased less in the Git2/ mice than in
Git2+/+ mice, whereas the inflammation inhibitory cytokine IL-10
increased to a markedly higher level in Git2/ mice. The expres-
sion levels of several major inflammatory mediators, including
MIP-1a, MCP-1 and CXCL10, which have been reported to be
important in Con A-induced hepatitis pathogenesis, were also
found to be significantly lower in Git2/ mice than in Git2+/+ mice
after Con A injection.
We further examined the percentage of TNF-a-, IFN-c- and
IL-4-producing T cells in the liver MNC by intracellular staining.
As shown in Fig. 4C, there were no significant differences in the
percentages of TNF-a-, IFN-c- and IL-4-producing T cells isolated
from the liver of Git2/ and Git2+/+ mice. One hour after Con A
treatment, compared with Git2+/+ mice, the percentages of
TNF-a-, IFN-c- and IL-4-producing T cells were increased to a
markedly lower degree in the liver of Git2/ mice. These data sug-
gest that less production of proinflammatory cytokines associated
with GIT2 absence may contribute to protection mice from hepatic
injury.
2.4. GIT2 depletion suppressed the activation and function of mouse
CD4+ T cells
To further clarify the mechanisms underlying the GIT2
depletion-induced inhibition of Con A-induced hepatitis, weels from Git2+/+ and Git2/mice (n = 3) were determined at 12 h following injection
ter 1 ml/kg (1:3 diluted in corn oil) CCl4 injection, mice were sacrificed and the liver
gical analysis. Scare bar, 200 lm. The percentage of necrotic area was quantitated
Fig. 3. GIT2 depletion suppressed lymphoid cells infiltration to liver after Con A treatment. Liver MNC and splenocyte from Git2+/+ and Git2/mice (n = 6) were isolated at 6 h
after 15 mg/kg Con A injection. (A) Cell numbers of total liver MNC, CD4+, CD8+, CD19+, NK, and NKT were quantified. (B) Cell numbers and percentage of Tregs were
quantified. (C) Cell numbers of total splenocyte, splenic CD4+, splenic Tregs and Tregs percentage were quantified. (D) Cells were labeled with PI and annexin V–FITC and then
analyzed by FACS. The results were representative of three independent experiments and error bars represent standard deviations (*P < 0.05, **P < 0.01).
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of mouse CD4+ T cells in vitro. Purified splenic CD4+ T cells from
Git2/ and Git2+/+ mice were treated with Con A, anti-CD3 plus
anti-CD28, or PMA/ionomycin, and flow cytometry was performed
to examine the activation markers CD25 and CD69. As shown in
Fig. 5A, the expression level of CD25 on CD4+ T cells was signifi-
cantly weaker in Git2/ mice than in Git2+/+ mice after treatment
with Con A. GIT2 depletion also inhibited the Con A-induced
expressions of CD69 on CD4+ T cells (data not shown).
The CD4+ T cells were stimulated with Con A, anti-CD3 and anti-
CD28, PMA/ionomycin in vitro for 72 h respectively, and the prolif-
eration was examined at 2 h after BrdU labeling. As shown in
Fig. 5B, Con A and anti-CD3/anti-CD28 mAb can stimulate both
CD4+ T cells from Git2/ mice and Git2+/+ mice whereas the rate
of proliferation was significantly faster in the Git2+/+ CD4+ T cells
(P < 0.05), while the effect of PMA/ionomycin treatment showed
no difference between Git2+/+ and Git2/ CD4+ T cells. In addition,
the cell division was confirmed by CFSE analyses. Splenocytes from
Git2+/+ and Git2/ mice were labeled with CFSE in vitro and stim-
ulated with plate-bound anti-CD3+ soluble anti-CD28 for 72 h, or
with Con A for 5 d, and CD4+ T cells were gated for analyses.
Similar division patterns were observed after stimulation with
Con A, or anti-CD3/anti-CD28 mAb (Fig. 5C).To investigate whether CD4+ T cells from Git2/ mice can
produce sufficient levels of cytokines, we compared the amounts
of IL-2, IFNc and TNFa produced by the splenic CD4+ T cells from
Git2/ and Git2+/+ mice after Con A, anti-CD3 plus anti-CD28, or
PMA/ionomycin stimulation. The results showed a significantly
reduced production of TNF-a, IL-2 and IFN-c by Git2/ CD4+ T cells
than by those from Git2+/+ mice after stimulation with Con A or
anti-CD3 plus anti-CD28 (Fig. 5D). However, PMA/ionomycin
induced normal levels of TNF-a, IL-2 and IFNc in Git2/ CD4+ T
cells (Fig. 5D). Furthermore, we assessed the amounts of TNF-a,
INF-c, IL-2, IL-4, IL-6, and IL-17A produced by splenic CD4+ T cells
from Git2/ and Git2+/+ mice after induction with different doses
of Con A. As shown in Fig. 5E, compared with Git2+/+ mice, there
was a significant decrease in the production of proinflammatory
cytokines by T cells from Git2/ mice. These data suggest that
GIT2 is required for CD4+ T cells activation which likely explains
the reduction in CD4+ T cells in GIT2/mice after Con A treatment.
2.5. Impaired TCR-mediated signal transduction in CD4+ T cells from
GIT2-depleted mice
The defects in T-cell activation phenotype are often due to
impaired TCR-induced signaling events. To demonstrate the
Fig. 3 (continued)
Table 2
Liver MNC subsets in Git2+/+ and Git2/ mice [mean ± SD, n = 6].
Cells (%) Git2+/+ Git2/
Control Con A Control Con A Pa Pb
CD4 34.6 ± 4.7 23.65 ± 3.3 19.56 ± 2.1*** 12.93 ± 0.3* 0.000103 0.0149
CD8 10.89 ± 2.7 8.15 ± 0.5 16.06 ± 2.1** 9.36 ± 1.4 0.00468 0.329
NK 46.46 ± 1.6 23.06 ± 2.2 37.76 ± 4.8* 44.93 ± 3.9** 0.0419 0.00113
NKT 35.7 ± 3.6 3.49 ± 1.9 24.56 ± 0.9** 2.5 ± 1.6 0.00695 0.536
CD19 26 ± 3.5 22.66 ± 7.9 22.2 ± 2.1 10.34667 ± 2.4 0.322 0.0631
Pa versus Git2+/+ mice untreated.
Pb versus Git2+/+ mice at 6 h after Con A injection.
Liver MNC from Git2+/+ and Git2/ mice (n = 6) were isolated at 6 h after 15 mg/kg Con A injection. The percentage of CD4+, CD8+, CD19+, NK, and NKT in liver MNC were
analyzed by FACS using FITC-, PE-, APC-conjugated mAbs.
* P < 0.05.
** P < 0.01.
*** P < 0.001 versus Git2+/+ mice.
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cells, we assessed the activation of several signaling molecules
downstream of the TCR. As shown in Fig. 6A, GIT2-difecient T cells
did not show any substantial defects in phosphorylation of ERK1/2
after anti-CD3 plus anti-CD28 or Con A stimulation. However, a
significant increase in phosphorylation of PAK was observed in
wildtype T cells but not in GIT2-deficient T cells (Fig. 6A).
Likewise, Rac activation occurred as early as 1 min following
anti-CD3 plus anti-CD28 stimulation in wildtype T cells, whereasdeficiency in GIT2 resulted in later Rac activation with a peak
induction at 5 min post TCR stimulation (Fig. 6B). It has been
reported that GIT2 is required for PAK activation upon formation
of the immunological synapse. We therefore measured the total
amount of cellular F-actin assembled after TCR stimulation. We
found that anti-CD3 plus anti-CD28 induced F-actin assembly sim-
ilarly in wildtype and Git2/ T cells (Fig. 6C). However, we noted
that polarized F-actin assembly appeared in wildtype but not
Git2/ T cells upon anti-CD3 plus anti-CD28 stimulation
Fig. 4. Lower levels of proinflammatory cytokines in Git2/ mice after Con A injection. Git2+/+ and Git2/ mice (n = 3) were injected in tail vein with 15 mg/kg Con A. (A)
Serum levels of cytokine were determined at indicated time points after Con A injection by ELISA. (B) The mRNA levels of the cytokines in the hepatic homogenate were
determined at indicated time points after Con A injection by real-time PCR. The expression levels for the target genes were normalized to GAPDH. The real-time PCR
procedure was performed three times. (C) Liver MNCs were isolated 1 h after Con A injection and labeled with FITC- or APC-conjugated CD3 antibody following with stained
with FITC-, PE-, APC-conjugated indicated antibodies and analyzed by FACS. The results were representative of three independent experiments and error bars represent
standard deviations (*P < 0.05, **P < 0.01, ***P < 0.001).
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TCR-mediated signal transduction in T cells.
2.6. GIT2 increased protein stability of aPIX
Because GIT2 regulates diverse cellular functions through inter-
acting with various proteins, we analyzed the protein levels of GIT2
partners, such as PAK, PIX, Rac1 and Cdc42. The results showed
similar expression of PAK, Rac1, or Cdc42; except for the reduction
of PIX expression in GIT2-deficient T cells (Fig. 7A). The reduction
in PIX protein was further confirmed in the thymus, spleens, and
lymph nodes of Git2/mice using an anti-PIX antibody that recog-
nizes both aPIX and bPIX (Fig. 7B). This effect of GIT2 on the PIX
protein levels was found to not be due to changes in their tran-
scription because GIT2 deficiency did not significantly alter the
abundance of PIX mRNA in the thymus and spleens cells(Fig. 7C). Moreover, compared with control cells, a clear reduction
in PIX stability was observed in GIT2-deficient T cells. In contrast,
the PIX half-life was higher than 36 h in wild-type GIT2 cells and
was shortened to 8–10 h in GIT2-deficient T cells (Fig. 7D). To
demonstrate that the reduction in the PIX protein levels was a
direct consequence of GIT2 deficiency, we reestablished the wild-
type GIT2 expression levels in GIT2-deficient T cells using a
lentivirus-based approach. The expression of full-length GIT2 led
to a significant increase in the PIX steady-state protein levels
(Fig. 7E).3. Discussion
In this study, we provide the first evidence that GIT2 plays an
important role in the pathogenesis of Con A-induced hepatitis.
Fig. 4 (continued)
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attenuated liver injury, which was associated with reductions in
the number of effector cells, namely T lymphocytes (both CD4+
and CD8+), CD19+ B lymphocytes and NKT cells, accompanied by
lower serum levels of TNF alpha, IFN gamma, IL-2, IL-4, and IL-17
and an increase in the serum level of IL-10.
The flow cytometry analyses of liver lymphocytes from GIT2-
deficient mice showed a relative increase in CD8+ T cells and reduc-
tions in CD4+ and NKT cells under basal conditions. The CD4+/CD8+
ratio is a reflection of immune system health, and its decrease or
increase indicates a dysfunction of the immune system [18,19].
In our study, in accordance with previous reports [13], Git2/mice
often developed splenomegaly, suggesting that Git2/ mice may
be highly susceptible to infection, which may occur sporadically
with some pathogens even in specific pathogen-free housing con-
ditions. This result indicated that the loss of GIT2 in vivo led to
an immunodeficient state.The infiltration of lymphocytes into the liver is critical for the
development of Con A-induced hepatitis. We found that the tar-
geted disruption of the GIT2 gene led to a suppression of the infil-
tration of MNCs, particularly CD4+ and CD8+ lymphocytes. Two
possible mechanisms may be involved in the reduction in the num-
ber of liver-infiltrating effector cells after the loss of GIT2. (1)
Inflammatory responses to injury are characterized by increased
lymphocyte binding to and migration across sinusoidal endothelial
cells that line the hepatic sinusoidal microvasculature [20,21].
Lymphocytes interact with the sinusoidal endothelium via adhe-
sion receptors, including intercellular adhesion molecular-1
(ICAM-1), and ICAM-1-deficient mice demonstrate reduced leuko-
cyte adhesion to hepatic sinusoids [22,23]. In our study, we found
that the expression of ICAM-1 in the hepatic homogenate from
Git2/ mice was significantly diminished compared with that
found in the homogenate from Git2+/+ mice, which may lead to less
T cells are recruited to the liver where they drive immune-
Fig. 4 (continued)
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cyte trafficking to the liver, and in particular, chemokines secreted
by liver cells contribute to the compartmentalization of lympho-
cyte recruitment within the liver [21,24]. It has been reported that
the gene ablation of GIT2 in mouse neutrophils results in defective
chemotaxis toward GPCR ligands, fMLP and C5a [13]. In our study,
we measured the expression of several chemoattractant factors in
hepatic homogenates and found that the loss of Git2 significantly
suppressed the mRNA expression of MIP-1a [CCL3] and CXCL10,
which may affect the attraction of effector cells in the liver of
Git2/ mice after Con A injection.
After infiltration into the liver tissue, T cell recognition of the
antigen presented by a dendritic cell results in an activated effector
T cell and the production of large amounts of cytokines, such as
tumor necrosis factor alpha (TNFa) and interferon gamma (IFNc),
contributing to hepatocyte necrosis and apoptosis [25,26]. In this
study, we found that GIT2-deficient T cells showed marked impair-
ments in T cell functions following TCR stimulation, including poor
activation phenotypes of CD25 and CD69 expression, proliferation
and cytokine production, compared with those fromWTmice, sug-
gesting that GIT2 plays an important role in the activation of T
lymphocytes. We further showed that stimulation with PMA plus
ionomycin, which bypasses the TCR complex, resulted in similar
T cell proliferation and cytokine production in WT and Git2/
mice. PMA is a DAG analog which can pass through cell membrane
freely and activates PKC directly. Ionomycin is a Ca2+ ionophore
which can raise intracellular Ca2+ levels and stimulate calcineurin.
It has been reported that calcineurin cooperated with PKC to trans-
duce mitogenic signals and led to the activation of the transcrip-
tion factors AP-1 and NF-AT, which are involved in IL-2 gene
induction [27]. Therefore, it seems that GIT2 regulates relatively
‘upstream’ events in TCR signaling. Various signaling events occur
after TCRs bind to pMHC on antigen-presenting cells (APCs) to ini-
tiate and sustain T cell activation, including protein phosphoryla-
tion, generating immunological synapse, intracellular calcium
flux, small GTPase activation, cytoskeletal remodeling, and tran-
scription factor activation [28]. In these intracellular signaling
transduction processes, one group of signaling proteins, such as
Grb2, Gads, and SLP-76, which are collectively termed ‘‘adapter”or ‘‘linker” proteins, are essential for T cell activation by mediating
TCR signaling [29]. The function of the GIT2 protein in the regula-
tion of the cytoskeletal structure, membrane trafficking and the
scaffolding of signaling cascades have been described in detail
[5], which suggested that GIT2 may be involved in T cell activation
as a kind of linker proteins. In this study, we found that GIT2-
deficient T cells displayed distempered TCR signaling events, such
as PAK phosphorylation. A previous study showed that GIT2 inter-
acts with PIX and PAK constitutively in a tri-molecular complex in
T cells, and PIX-deficient T cells displayed defective TCR-induced
proliferation and signaling [12]. In addition, it has been shown that
neutrophils from either GIT2- or aPIX-knockout animals present
impaired chemotactic responses [12,13]. The phenotype resem-
blance between the Git2/ and PIX/mice suggest that these pro-
teins may regulate T cell function through similar mechanisms.
Interestingly, we found that the PIX protein level is marked
reduced in GIT2-deficient T cells. We also provide evidence that
Git2 increased the protein stability of aPIX, similarly to how PIX
stabilizes GIT2 in lymphocytes. Therefore, whether the functional
defects in the Git2/ T cells may be due to the loss of Git2 or
PIX remain to be investigated.
NKT cells are a heterogeneous group of T lymphocytes that
express both the NK1.1 receptor and the TCR. It has been reported
that NKT cells are abundant in the liver and play an important role
in Con A-induced hepatitis via secretion of proinflammatory
cytokines such as IFN-c. In our research, we found that liver lym-
phocytes in GIT2 deficient mice showed reduce in NKT cells in
basal conditions, which may lead to less secretion of IFN-c upon
Con A administration. Moreover, we found that CD3+NK1.1+NKT
cells are markedly decreased 6 h after Con A injection, in agree-
ment with other researchers [17]. There are two possibilities for
the mechanisms associated with the change in the NKT cell num-
ber at the early stage of Con A-induced liver injury. First, Con A
induced FasL expression on NKT cells not only resulted in liver
injury but also led to apoptosis of activated NKT cells in the liver
[30]. Second, activation of NKT cells upon Con A administration
may lead to a dynamic response characterized by surface markers
down-modulation, which has been found in the response of NKT
cells to glycolipid antigens [31]. Although we observed a decrease
Fig. 5. Defective TCR-induced CD4+ T cell activation, proliferation, and cytokine production in the absence of GIT2. CD4+ T cells were purified from the spleens of the Git2+/+
and Git2/mice. (A) CD25 expression was measured by FACS at 24 h after 2.5 lg/ml Con A treatment as indicated. (B) The CD4+ T cells were stimulated with Con A, anti-CD3
and anti-CD28, PMA/ionomycin as indicated for panel added in vitro for 72 h respectively, and the proliferation was examined at 2 h after BrdU labeling. (C) 5 lM
CFSE-labeled splenocyte were stimulated with anti-CD3/CD28 Abs for 72 h or with Con A for 5 d. Cells were harvested and gated on CD4+ T cells for FACS. Unstimulated,
CFSE-labeled cells were used to verify the peak corresponding to the undivided population. (D) The cells were treated for 48 h as indicated for panel A, and supernatants were
collected. Amounts of TNF-a, IFN-c and IL-2 were determined by ELISA. (E) The cells were treated as indicated for 48 h, and supernatants were collected. Amounts of
TNF-a, IFN-c, IL-2, IL-4, IL-6, and IL-17 were determined by ELISA. The results were representative of three independent experiments and error bars represent standard
deviations (*P < 0.05, **P < 0.01, ***P < 0.001).
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levels in Git2/ and Git2+/+ mice were equivalent 6 h after Con A
injection. Thus, NKT cells may not be the major effector cells
involved in the process of inhibition of hepatitis by Git2 deficiency.
CD4+CD25+Foxp3+ regulatory T (Treg) cells have been shown to
be implicated in a number of pathologic processes, such as cancers,
infectious disease, and autoimmune disease [32,33]. Foxp3 is a
critical regulator of Treg development and function which is sup-
ported by the fact that the lethal lymphoproliferative autoimmune
syndrome observed in Foxp3-deficient mice resulted from a difi-
cienty in CD25+CD4+ Tregs [34]. Furthermore, Foxp3 is currently
the most specific and reliable molecular marker for natural Tregs
in rodents and human [35,36]. In this study, we demonstrated that
the deletion of GIT2 increased the percentage of Tregs in liver and
spleen and increased the number of CD4+CD25+Foxp3+ cells in
spleen compared with Git2+/+ mice after Con A injection.
Consistent with this observation, we clearly showed a significantly
elevated level of IL-10, which is one of the downstream effectors
induced by Foxp3, in the serum of Git2/ compared withWTmice.
Although the physiological factors and pathways initiating intra-
cellular Foxp3 expression and promoting its immune regulatory
characteristics remain poorly understood, recent studies haverevealed that disruption of the signaling components of the NF-
jB pathway, including NF-jB-inducing kinase (NIK) and TNF
receptor-associated factor 6 (Traf6), leads to impairments in regu-
latory T cell generation [37,38]. It was recently reported that GIT2
may terminate TLR-induced NF-jB and MAPK signaling by recruit-
ing the deubiquitinating enzyme cylindromatosis to inhibit the
ubiquitination of TRAF6 [39]. Therefore, the higher number of
CD4+CD25+Foxp3+ cells found in the mice lacking Git2 may be
due to the loss of negative regulation of Toll-like receptor
(TLR)-induced NF-jB signaling. Furthermore, given that impaired
Treg suppressive activity is associated with impaired activation
of the GIT–PIX–PAK complex [40], it would be important to
compare the suppressive activity of Treg from WT versus KO mice
in a standard in vitro Treg suppression assay. However, we did not
observe the obvious difference in suppressive activity between WT
versus KO mice (Fig. 9), the reason of which should be studied
further.
Because the longest splice form of GIT2 (GIT2-long) is widely
expressed, including in the heart, brain, spleen, lung, kidney, liver,
muscle, and testis, whether hepatic cells are also responsible for
the Git2/ phenotype associated with the reduced response to
Con A hepatitis should be studied further [6]. Given that the
Fig. 5 (continued)
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and that PAK1 is important for cellular survival and proliferation
[9,10,41], GIT2 also might regulate hepatocyte survival through
control of PAK1 signaling. Although we showed no significant dif-
ference in CCl4-induced liver injury between Git2/ and WT mice,
which suggests that GIT2 deficiency may not affect parenchymal
function, experiments involving bone marrow chimeras between
GIT2 knockout and wild-type mice may finally help to delineate
the parenchymal effects.
In summary, this study provides the first demonstration that
GIT2 deficiency protects mice from Con A-induced hepatitis by
suppressing the function of activated T cells and reducing theintrahepatic infiltration of inflammatory cells. Further work is
required to evaluate GIT2 as a potential target in hepatitis in
humans.
4. Materials and methods
4.1. Mice
Git2+/ mice were obtained from Osaka Bioscience Institute
(Japan) and Git2/ mice were generated by intercrossing of
Git2+/ mice [13]. All mice were housed in a SPF conditions and
the protocols used for all animal experiments in this study were
Fig. 5 (continued)
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Radiation Medicine Animal Center (Beijing, China).
4.2. Antibodies
All antibodies were purchased from commercial sources:
CD3-phycoerythrin (PE), CD4-allophycocyanin (APC), CD4-peridi
nin-chlorophyll–protein complex (PerCP), CD19-PE, CD3-APC,
CD3-fluorescein isothiocyanate (FITC), CD8-PE, NK1.1-APC,
F4/80-PE, CD11c-PE, CD11c-APC, IL-4-PE, IFN-c-APC, TNFa-FITC,
CD69-APC, anti-CD3 Abs, and anti-CD28 Abs from eBioscience;
Rabbit polyclonal GIT2 Abs, anti-phospho-PAK1/2 (Ser199/204 of
PAK1 and Ser192/197 of PAK2 Abs, and anti-phospho-c-Cbl
(Y774) Abs from Cell Signaling; Anti-phospho-Erk1/2 (E4) Abs,
anti-PAKa, anti-Erk1/2 (K23) from Santa Cruz.
4.3. PCR, reverse-transcription and real-time PCR
Genomic DNA was prepared as described previously and the
genotypes of the mice were determined by PCR [13,42]. The
oligonucleotide PCR primers that were used to distinguish the tar-
geted allele from the wild-type allele were as follows: GIT2-S1, 50-
TGCAGGGTCATTGGAGAGTGAATGAGGCTA-30; GIT2-S2, 50-GGTTTG
AGCAAGAGAACTCATCGGTCCAAG-30 and Neo, 50-CTCGTGCTTTACG
GTATCGCC-30. The GIT2-S1 and GIT2-S2 primers gave an 1131-bp
DNA fragment to identify the WT allele, whereas the GIT2-S2
and Neo primers yielded the 650-bp fragment of the target allele.
The PCR was carried out for 30 cycles consisting of 94 C, 1 min;
60 C, 30 s and 72 C, 2 min.
Reverse-transcription and real-time PCR were performed as
described previously [43]. Specific primers for each gene were
listed in Table 3.
4.4. Cell purification, cell surface labeling, and flow cytometry
Mice were sacrificed via cervical dislocation. Thymuses, spleens,
lymph nodes, and bone marrow were dissected and crushed in
RPMI 1640 medium. Livers were passed through a 100 lm nylonmesh. The filtrate was centrifuged at 50 g for 5 min and the super-
natant was collected. Cells were suspended in a 40% percoll (GE
Healthcare) solution and overlaid on a 70% percoll solution. After
centrifugation with 800g for 20 min, the interphase was collected
and washed twice with PBS. For spleen and bone marrow cells
and liver mononuclear cells, samples were depleted of red blood
cells using lysis solution (100 mM NH4Cl, pH 7.4) no more than
5 min. Lymphocyte populations were characterized using FITC-,
PE-, APC-conjugated mAbs; for Tregs, Foxp3 detection kit
(eBioscience) was used, and analyzed by flow cytometry
(FACScan; BD Biosciences, San Jose, CA, USA) and FlowJo software
(Tree Star, Ashland, OR) was used for data analysis.
4.5. Cytokine detection
For detection of various cytokines, plasma samples were col-
lected from mice or cells at indicated time after Con A injection
and immediately frozen at 70 C and stored until use. BD
Cytometric Bead Array (CBA) Mouse Th1/Th2/Th17 Cytokine Kit
(for GM-CSF, IL-1b, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12, IFN-c and
tumor necrosis factor (TNF)-a) was purchased from BD
Biosciences. All procedures were performed according to the man-
ufacturer’s protocol.
4.6. Experimental acute toxic hepatitis model
Con A was dissolved in sterile PBS and injected in the tail vein at
the dose of 15 mg/kg (for liver pathology) of bodyweight as indi-
cated. For assessment of liver damage, mice were sacrificed at
the indicated time points, and serum and liver specimens were
collected.
4.7. Alanine aminotransferase (ALT) and aspartate aminotransferase
(AST) assay
Serum activities of ALT and AST were measured with an auto-
analyser (Hitachi 7020 automatic analyser, Hitachi, Tokyo, Japan)
and expressed in IU/L.
Fig. 6. Defective TCR-induced signaling in the absence of GIT2. Purified splenic T cells from the Git2+/+ and Git2/ mice were stimulated by 5 lg/ml anti-CD3 plus 2 lg/ml
anti-CD28 at indicated time. (A) ERK1/2 and PAK phosphorylation were analyzed using phospho-specific antibodies. Nonphosphorylated proteins served as a control. The
immunoblot bands were scanned for densitometry analysis with the value obtained from control cells set as 1 (bottom). The results were representative of three independent
experiments and error bars represent standard deviations (*P < 0.05). (B) Cell extracts were incubated with glutathione S-transferase-PAK RBD to precipitate GTP-bound Rac1
(Rac1-GTP). Anti-Rac1 antibody was used to detect GTP-bound GTPases. Total Rac1 served as a control. The immunoblot bands were scanned for densitometry analysis with
the value obtained from control cells set as 1 (right). The results were representative of three independent experiments and error bars represent standard deviations
(*P < 0.05). (C and D) The cells were fixed, stained with FITC-phalloidin and anti-CD3, and analyzed by confocal and FACS. All data are representative of at least three
independent experiments, Scale bar, 10 lm. All data are representative of at least three independent experiments.
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Fig. 7. GIT2 Increased Protein Stability of aPIX. (A) Purified splenic T cells from the Git2+/+ and Git2/ mice were analyzed for the expression of PAK, PIX, Rac1, and CDC42 by
western-blot. Antibodies against the GAPDH served as a control. (B) Cell homogenates from the indicated tissues from the Git2+/+ and Git2/ mice were resolved by SDS–
PAGE and immunoblotted with a polyclonal anti-PIX antibody. (C) Expression analysis of aPIX or bPIX in indicated tissues by real-time PCR using primers recognizing either
aPIX or bPIX. (D) Purified splenic T cells from the Git2+/+ and Git2/mice were cultured on 24-well plates with or without 50 lg/ml of cycloheximide (CHX) for the indicated
times. (E) Purified splenic T cells from the Git2/mice were cultured on 24-well plates and infected with pBPLV-GIT2 or mock virus. 24 h later, the cells were treated with or
without 50 lg/ml of cycloheximide (CHX) for the indicated times. aPIX and GIT2 expression were analyzed by Western blotting. Antibodies against the GAPDH served as a
control. For (D) & (E), the immunoblot bands were scanned for densitometry analysis with the value obtained from control cells set as 1 (bottom). The results were
representative of three independent experiments and error bars represent standard deviations (*P < 0.05).
Fig. 8. The effect of GIT2 depletion on the expression of ICAM-1. The mRNA levels of
ICAM-1 in the hepatic homogenate were determined by real-time PCR.
he expression levels for the target genes were normalized to GAPDH. The
real-time PCR procedure was performed three times. The results were represen-
tative of three independent experiments and error bars represent standard
deviations (*P < 0.05).
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transferase-mediated dUTP nick-end labeling (TUNEL) assay
Formalin-fixed, paraffin-embedded liver sections were stained
with hematoxylin–eosin for the histological investigations to eval-
uate the degree of necrosis after acute liver injury, which is based
on severity of necrotic lesions in the liver parenchyma.
The TUNEL assay was performed using The DeadEnd
Colorimetric TUNEL System (Promega) according to the manufac-
turer’s protocol. The TUNEL-positive cells were quantitated by light
microscopy. Five (3200 magnification) fields were randomly
selected per slide and 100 hepatocytes counted per field. The mean
percentage of apoptotic hepatocytes was calculated and compared
between different study groups.
4.9. Intracellular cytokines detection
Liver MNCs were extracted from mice 1 h after Con A injection
and were resuspended to a density of 107 cells/ml and 100-ll
Fig. 9. The effect of isolated Tregs on proliferation of responder cells. CD4+CD25 responders were labeled with CFSE and cultured alone or with CD4+CD25+ Tregs at a ratio of
2:1 in the presence of 5 lg/ml Con A. Cells were harvested and gated on CD4+CD25 T cells for FACS. Unstimulated, CFSE-labeled cells were used to verify the peak
corresponding to the undivided population.
Table 3
Sequences of primers used for real-time PCR.
Primers Sequence[50 ? 30]
IL-2 forward GTCAACAGCGCACCCACTT
IL-2 reverse TGCTTCCGCTGTAGAGCTTG
IL-4 forward ACAGGAGAAGGGACGCCAT
IL-4 reverse GAAGCCCTACAGACGAGCTCA
IL-6 forward GAGGATACCACTCCCAACAGACC
IL-6 reverse AAGTGCATCATCGTTGTTCATACA
IL-10 forward TGGCCCAGAAATCAAGGAGC
IL-10 reverse CAGCAGACTCAATACACACT
TNF-a forward CTGTAGCCCACGTCGTAGC
TNF-a reverse TTGAGATCCATGCCGTTG
INF-c forward TCAAGTGGCATAGATGTGGAAGAA
INF-c reverse TGGCTCTGCAGGATTTTCATG
MCP-1 forward GCTGGAGAGCTACAAGAGGATCA
MCP-1 reverse CCTCTCTCTTGAGCTTGGTGACA
MIP-1a forward GCGCCATATGGAGCTGACAC
MIP-1a reverse TCAGGCATTCAGTTCCAGGT
CXCL10 forward CCGTCATTTTCTGCCTCATCCT
CXCL10 reverse T CTCCACATTGTCTTTTGACCT
ICAM-1 forward CCATCACCGTGTATTCGT
ICAM-1 reverse GCTGGCGGCTCAGTATCT
702 E. Hao et al. / FEBS Open Bio 5 (2015) 688–704aliquots of the cell suspension were distributed into tubes for cell
surface staining. Cells were incubated with FITC-conjugated CD3
antibody (for IFN-c and IL-4) or APC-conjugated CD3 antibody
(for TNFa) in the dark at 4 C for 30 min. The cells were washed
once with RPM1 1640 with 2% FBS and spun at 800g, 4 C for
5 min. They were fixed and permeabilized with Cytofix/Cytoperm
solution (20 min at 4 C). Then, the cells were washed twice in
Perm/Wash solution, and pelleted cells were stained (30 min at4 C) for intracellular cytokines by using PE-conjugated IL-4 anti-
body and APC-conjugated IFN-c antibody, and FITC-conjugated
TNFa antibody. PE, APC, or FITC-conjugated isotype controls were
used in parallel. After the cells were washed twice in PBS with
0.1% BSA, the cells were suspended in PBS–BSA and analyzed
immediately by flow cytometry (FACScan; BD Biosciences, San
Jose, CA, USA) and FlowJo software (Tree Star, Ashland, OR) was
used for data analysis.
4.10. CD4+ T-cell preparation and activation assay
CD4+ T cells from the spleens of the mice were affinity purified
using MACS isolation beads. The purity of the purified CD4+ T cells
was 94–99%, as determined by flow cytometry (FACScan; BD
Biosciences, San Jose, CA, USA) and FlowJo software (Tree Star,
Ashland, OR) was used for data analysis.
Cells were treated with 2.5 lg/ml Con A, or 5 lg/ml anti-CD3
antibodies plus 2 lg/ml CD28 antibodies, or 5 ng/ml PMA/0.5 lg/
ml ionomycin. The activation phenotypes of CD25 and CD69
expressions were measured by FACS analysis. Proliferation was
determined after 72 h using a BrdU Cell Proliferation Assay Kit
(Cell Signaling Technology).
4.11. CFSE analysis
CFSE labeling was performed as described previously with a lit-
tle change [44]. Briefly, 1  107 cells were suspended in 1 ml
serum-free medium (DKW34-EU0100, DAKEWE, China); 5 ll of
1 mM CFSE (LC01, Dojindo Laboratories) was added, and cells were
incubated at 37 C for 15 min with frequent mixing. An equal
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PBS. Cells were resuspended in serum-free medium (1  106/ml)
and seeded in 96-well flat-bottom culture plates. The cell division
status of cells was determined by measuring CFSE fluorescence at
indicated time. CFSE fluorescence was detected with the FL1
detector (488 nm). Data were analyzed using Cell Quest (BD
Biosciences).
4.12. Isolation of CD4+CD25+ Tregs and responder T cells
The isolation was performed using magnetic bead separation
(CD4+CD25+ Regulatory T Cell Isolation Kit, mouse, Miltenyi
Biotec) according to the protocol. Briefly, CD4+ T cell were enriched
using a biotinylated antibody cocktail and anti-biotin microbeads
by depletion of all non-CD4+ T cells. CD4+CD25+ T cells were iso-
lated by positive selection using PE-labeled anti-CD25 MAb and
anti-PE microbeads.
4.13. Stimulation of cytokine secretion in vitro
CD4+ T cell from the spleens of the mice were incubated at a
density of 2  105 per well in a 96-well plate. Cells were stimulated
with Con A at various concentrations (1, 2.5, or 5 lg/ml) for up to
48 h. Supernatants (100 ll) were taken and immediately frozen at
70 C and stored until detection with BD Cytometric Bead
Array (CBA) Mouse Th1/Th2/Th17 Cytokine Kit (for GM-CSF,
IL-1b, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12, IFN-c and tumor necrosis
factor (TNF) a).
4.14. Lentiviral constructs and transduction
For overexpression of GIT2 in T cells, the ViraPower lentiviral
expression system was used according to the manufacturer’s pro-
tocol (Invitrogen). The cDNA fragment encoding mouse GIT2 was
cloned into the lentivirus expression plasmid pBPLV, which has
two CMV promoters and an IRES-GFP tag, and construct pBPLV-
GIT2. The recombinant vector pBPLV-GIT2 expresses GIT2 protein
and GFP protein simultaneously. 293FT cells were transfected
using Lipofectamine 2000 (Invitrogen). Lentiviruses were concen-
trated at 4 C by centrifugation. Cells transduced with pBPLV vec-
tors were cultured in liquid medium for 48 h and then purified
by FACS sorting for GFP expression.
4.15. Statistical analysis
Statistical analysis was performed using SPSS18.0 software. The
statistical significance of differences between two sample groups
was assessed by the t-test, between multiple groups with multi-
level was assessed by factorial analysis. One-way ANOVA analysis
was used in group with multi-level. When met heterogeneity of
variance, select the Welch statistic in one-way ANOVA analysis.
P < 0.05 difference was statistically significant.
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